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Background: Pseudomnas putida is a natural producer of medium chain length polyhydroxyalkanoates (mcl-PHA),
a polymeric precursor of bioplastics. A two-fold increase of mcl-PHA production via inactivation of the glucose
dehydrogenase gene gcd, limiting the metabolic flux towards side products like gluconate was achieved before.
Here, we investigated the overproduction of enzymes catalyzing limiting steps of mcl-PHA precursor formation.
Results: A genome-based in silico model for P. putida KT2440 metabolism was employed to identify potential
genetic targets to be engineered for the improvement of mcl-PHA production using glucose as sole carbon source.
Here, overproduction of pyruvate dehydrogenase subunit AcoA in the P. putida KT2440 wild type and the Δgcd
mutant strains led to an increase of PHA production. In controlled bioreactor batch fermentations PHA production
was increased by 33% in the acoA overexpressing wild type and 121% in the acoA overexpressing Δgcd strain in
comparison to P. putida KT2440. Overexpression of pgl-encoding 6-phosphoglucolactonase did not influence PHA
production. Transcriptome analyses of engineered PHA producing P. putida in comparison to its parental strains
revealed the induction of genes encoding glucose 6-phosphate dehydrogenase and pyruvate dehydrogenase.
In addition, NADPH seems to be quantitatively consumed for efficient PHA synthesis, since a direct relationship
between low levels of NADPH and high concentrations of the biopolymer were observed. In contrast, intracellular
levels of NADH were found increased in PHA producing organisms.
Conclusion: Production of mcl-PHAs was enhanced in P. putida when grown on glucose via overproduction of a
pyruvate dehydrogenase subunit (AcoA) in combination with a deletion of the glucose dehydrogenase (gcd) gene
as predicted by in silico elementary flux mode analysis.
Keywords: Medium chain length polyhydroxyalkanoate, Pseudomonas putida, Systems metabolic engineering,
Pyruvate dehydrogenase, GlucoseBackground
Metabolic engineering of microorganisms has significantly
contributed to the biotechnological production of chemicals
in a sustainable manner [1,2]. Insertion of heterologous
pathways and modification of the host metabolism,
via deletion or amplification of genes, has been a common
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article, unless otherwise stated.[3,4]. Nevertheless, these modifications often evoke
detrimental effects on the cell metabolism which lead to
decreased growth and low performance of the constructed
cell factory [2,3,5]. In silico reconstruction of the metabolism
of bacterial production hosts in combination with metabolic
flux modeling can help to design the optimal pathways
towards a product of interest. Multiple efforts have
been made to engineer microorganisms to obtain
sustainable polymers which have the potential to replace
petroleum-based plastics. In this regard, medium-
chain-length polyhydroxyalkanoates (mcl-PHAs) are among
the most promising biodegradable polymers synthesizeded Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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applications [6]. Bacteria from the genus Pseudomonas are
natural producers of mcl-PHAs since they have the entire
machinery to synthesize these polyesters from different
carbon sources (Figure 1) [7]. They accumulate these
polymers as inclusion bodies in the cytoplasm promoted
preferentially by a high carbon supply and the limitation
of an inorganic nutrient such as nitrogen, oxygen, or
phosphorous [8]. As other PHA-accumulating bacteria,Figure 1 Central metabolism of P. putida KT2440. Enzymes of interest a
involvement are marked.Pseudomonas putida strains utilize PHAs as a reservoir
of carbon and energy to cope with the changing
environmental conditions of their natural habitats.
For decades, studies for biotechnological mcl-PHA
production focused on the use of fatty acid as carbon
source [9-12]. This approach led to PHA accumulation in
the cell, yielding more than 80% of its dry weight as PHA
[13]. Additionally, engineering of the β-oxidation pathway
in P. putida allowed for production of novel mcl-PHAs,re indicated. Enzymatic steps with NAD+/NADP and NADP+/NADPH
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and for biomaterials [10,14,15]. Much less attention has
been given to the engineering of metabolic pathways
involved in sugar or polyalcohol utilization in P. putida
[16]. It was reported that inactivation of the isocitrate lyase
gene resulted in a 1.7-fold increased production of
mcl-PHA using gluconate as carbon source [17].
Different waste materials were tested as feedstock
for PHA producing Pseudomonas species in order to
reduce the overall production cost. Pseudomonas spe-
cies accumulated mcl-PHAs when grown on sodium
terephthalate produced from a PET pyrolysis, raw gly-
cerol [18], polystyrene pyrolysis oil, and animal waste
lipids [19]. Glucose is still one of the cheapest and most
available feedstock for industrial polymer biosynthesis
[20]. However, only small amounts of mcl-PHAs are
currently synthesized utilizing glucose as carbon source
[21,22]. Most metabolic approaches for the improvement
of PHA production with glucose as carbon substrate were
performed using Escherichia coli [23-25]. After cloning
the PHA synthesis genes from Cupriavidus necator
(formerly known as Ralstonia eutropha) into E. coli higher
levels of NADPH versus NADP +were found essential to
promote PHB synthesis. Consequently, bioengineering
efforts on the rising of NADPH availability in turn to
improve PHA synthesis on glucose were undertaken.
Overproduction of glucose-6-phosphate dehydrogenase
(G6PDH encoded by zwf) increased the intracellular
NADPH levels and led to an increased accumulation of
PHA by 41% [26]. A similar approach was carried out with
C. necator, which resulted in an increased production of
PHA in the presence of fructose [27]. It is known that
Pseudomonas species prefer other carbon sources like
organic acids and amino acids over glucose [28].
Consequently, our research focused on the development
of P. putida strains which can accumulate high amounts
of mcl-PHA on glucose as the sole carbon source.
Recently, novel bioengineering approaches for an
optimized production from glucose were undertaken
[21]. Initially, a genome-based in silico model of the
P. putida metabolism was established and used for
the prediction of optimal fluxes towards PHA and its
precursor molecules. Among a list of different genetic
targets, elementary flux mode analysis suggested an
inactivation of glucose dehydrogenase encoded by gcd to
prevent undesired by-product formation and excretion. In
agreement with the prediction from the in silico model
the constructed P. putida Δgcd mutant strain showed an
increased PHA production in batch [13] and Fed-Batch
cultivations [29]. Here, we continued to experimen-
tally verify the predictions of our in silico model for
the optimization of mcl-PHA production in P. putida.
We tested for the proposed positive impact of the
overexpression of the genes for pyruvate dehydrogenase(acoA) and 6-phosphogluclactonase (pgl) on mcl-PHA
production.Results and discussion
Overexpression of the genes for the pyruvate
dehydrogenase AcoA and 6-phosphoglucolactonase Pgl
for improved PHA production
The acoA and pgl genes were separately cloned into the
broad host range vector pSEVA424 and then transformed
into the P. putida KT2440 and the Δgcd mutant
strains. A list of all used strains, vectors and primers
are summarized in Table 1. Wild type P. putida KT2440
and the corresponding Δgcd mutant strain carrying the
vector without insert served as controls. Cells were grown
in defined M9 mineral minimal medium supplemented
with 20 (g/L) glucose and 62.5 μg/mL streptomycin as
described in the Methods section. Protein production
was induced at an initial OD600nm of 0.05. Cells were
harvested after 60 hours by centrifugation prior to
protein composition analyses and PHA-extraction and
quantification. SDS-PAGE analysis was used to assess
the overproduction of the AcoA and the Pgl proteins.
Successful overproduction of AcoA (Mr = 35,000) and Pgl
(Mr = 23,000) was observed, which is in good agreement
to the deduced relative molecular mass of approximately
34,700 Da for AcoA and 25,500 Da for Pgl (Figure 2).Increased mcl-PHA production in P. putida by overexpression
of the pyruvate dehydrogenase gene acoA
In order to evaluate the effect of acoA and pgl overex-
pression on PHA versus biomass production GC-MS
analyses of the extracted PHA and biomass determination
were performed (Figure 3). Triplicate aerobic cultures of
P. putida strains KT2440 (wt), KT2440-acoA, KT2440-pgl,
KT2440Δgcd, KT2440Δgcd-acoA, and KT2440Δgcd-pgl
were tested. For this purpose, cells were grown in defined
minimal medium for 60 hours until glucose as the
sole carbon source was completely consumed (in all
tested strains no glucose was detected via HPLC at
60 hours). As predicted by the in silico design the
pyruvate dehydrogenase-producing KT2440-acoA and
KT2440Δgcd-acoA mutant strains both showed an in-
creased PHA content amassing 33.3 wt % and 42.1 wt
% as mcl-PHA, respectively (Figure 3A). This was not
the case for the phosphoglucolactonase-overproducing
KT2440-pgl (25.7 wt %) and KT2440Δgcd-pgl (33.2 wt %)
strains in which the PHA concentration remained at the
basic level. In addition, no obvious major changes of the
mcl-PHA momomer composition between the various
producing P. putida strains were observed (Table 2). Next,
the yield of biomass of engineered strains grown on
glucose was determined. As initially desired, the biomass
production of the various recombinant strains was
Table 1 Bacterial strains, plasmids and primers used in this study
Strains Relevant features/genotype* Source reference
E. coli




F’[proABlacIqZΔM15 Tn10(TetR Amy CmR)]
Stratagene
DH10b-acoA DH10b carrying the P. putida acoA gene cloned in pJET1.2 This study
DH10b-pgl DH10b carrying intermediate pgl gene cloned in pJET1.2 This study
XL10-Gold- acoA XL10-Gold harboring acoA overexpression vector pSEVAaco This study
XL10-Gold-pgl XL10-Gold harboring pgl overexpression vector pSEVApgl This study
P. putida
KT2440 Wild type DSMZ
KT2440-acoA KT2440 harboring acoA expression vector pSEVA424 This study
KT2440-pgl KT2440 harboring pgl expression vector pSEVA424 This study




KT2440 carrying the gcd knockout mutation harboring acoA overexpression vector pSEVAacoA This study
KT2440Δgcd-pgl KT2440 carrying the gcd knockout mutation harboring pgl overexpression vector pSEVApgl This study
Plasmids
pJET1.2 Carrier vector, toxin expressed upon self-ligation, Apr Fermentas
pSEVA424 Expression vector for P. putida, IPTG-inducible, tac promoter, Smr De Lorenzo's Lab
pJET1.2-acoA Plasmid pJET1.2 carrying acoA gene for propagation, Apr This study
pJET1.2-pgl Plasmid pJET1.2 carrying pgl gene for propagation, Apr This study
pSEVA- acoA acoA overexpression vector, based on pSEVA424, Smr This study
pSEVA-pgl pgl overexpression vector, based on pSEVA424, Smr This study
Primers
acoAFw 5´CCGGAATTCAGGAGGAAAAACATATGTCCAATCAACTCAGT3 This study
acoARv 5′TGCTCTAGAGCATCAGGGGTAGGCGACGTA3′ This study
pglFw 5´CCGGAATTCAGGAGGAAAAACATATGGGAGGGCGTGGTATG3 This study
pglRv 5′TGCTCTAGAGCATCATGGGCACCAGTAGAT3′ This study
Apr = ampicillin resistance; Smr = streptomycin resistance.
¥Source the material was obtained from or reference. EcoRI and XbaI restriction sites are shown in italics. Shine Dalgarno (RBS) sequences are displayed in bold
whereas the eight conserved nucleotides upstream the RBS are depicted in bold and italics.
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type P. putida KT2440 strain (Figure 3B).
In summary, the most efficient PHA producer was
KT2440Δgcd-acoA strain, where the PHA concentration
was doubled compared to P. putida wild type strain
(Figure 3A) and enhanced by 21% compared to the
KT2440Δgcd mutant strain (Figure 3A). Thus, the
predicted engineering strategy was successful in in-
creasing the mcl-PHA synthesis of P. putida.
Batch fermentation in the bioreactors for controlled
mcl-PHA production
To ensure well-controlled mcl-PHA production using
our metabolically engineered P. putida strains, aer-
obic batch fermentations of the KT2440-acoA andKT2440Δgcd-acoA strains on glucose were performed in a
bioreactor. Figure 4 shows the time-resolved measure-
ments for mcl-PHA formation, biomass production and
the corresponding concentrations of ammonium, gluco-
nate, 2-ketogluconate, and glucose formation. As expected,
the KT2440-acoA strain, gluconate and 2-ketogluconate
were excreted into the medium during consumption of the
available glucose (Figure 4A, Table 3). In contrast, during
the fermentation of the flux optimized KT2440Δgcd-acoA
strain (Figure 4B) excreted organic acids were below the de-
tection limit (Table 3). A recent study compared mcl-PHA
synthesis in P. putida KT2440 and KT2442 when grown on
gluconate [30]. P. putida KT2440 accumulated 17% of its
CDW as PHA, whereas KT2442 only synthesized 1.7 wt %
as PHA, demonstrating the large differences between the
Figure 2 SDS-PAGE gels demonstrating the recombinant production of pyruvate dehydrogenase and 6-phosphogluconolactonase
by the recombinant P. putida strains. (A) Shown the separations of whole cell protein extracts from KT2440 (lane 1), KT2440-acoA (lane 2),
KT2440-pgl (lane 3), and (B) KT2440Δgcd (lane 4), KT2440Δgcd-acoA (lane 5) and KT2440Δgcd-pgl (lane 6).
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gluconate and 2-ketogluconate once secreted to the
medium. We recently demonstrated that this process is not
efficient to improve mcl-PHA synthesis [29], resulting in a
lower volumetric PHA productivity as compared to the one
shown by the Δgcd P. putida mutant strain under the same
growth conditions. Several investigations have shown
that the volumetric productivity is the key parameter for
the industrial production of PHAs and thus, any factor
influencing this parameter affects the economics andcost competitiveness of PHAs synthesis via microbial
fermentation [30-33]. Ammonium was completely con-
sumed at 12 hours by the KT2440-acoA strain, while
KT2440Δgcd-acoA took more than 15 hours to deplete
the entire amount of nitrogen. In addition, a large propor-
tion of carbon was directed towards gluconate in the
KT2440-acoA strain. More than 5 g/L of gluconate was
produced after 24 h, (Figure 4A). Furthermore, the lower
biomass of 2 g/L obtained for this strain prior ammonium
limitation was most likely due to the increased production
Figure 3 mcl-PHA (A) content and cell dry weight (B) of different metabolically engineered indicated P. putida strains.
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proteins due to less PHA formation. These findings might
explain the reduced PHA and biomass yield on glucose in
comparison to the KT2440Δgcd-acoA mutant strain.
The genetic modification of the KT2440Δgcd-acoA led to
the lowest μmax of all strains (0.25 h
−1 versus 0.56 h−1 for
KT2440). Nevertheless, the KT2440Δgcd-acoA strain
biomass (CDW = 4.71 g/L after 50 hrs) and mcl-PHA
42.1 wt % contents were higher in comparison to the
KT2440-acoA strain (CDW= 3.63 g/L after 50 hrs and
mcl-PHA= 33.3 wt %). To our knowledge this is the high-
est mcl-PHA accumulation ever reported using a P. putida
strain in the presence of glucose in batch cultures.
Transcriptome analysis of the engineered P. putida PHA
production strains
Glucose is metabolized in P. putida that utilizes three path-
ways converging at the level of 6-phosphogluconate prior
to the formation of 2-keto-3-deoxy-6-phosphogluconate
(KDPG; [34]). The repressor HexR regulates the expression
of major genes of the pathway including the zwf-1, pgl, eda
operon and the gap1 gene encoding glyceraldehyde-3-
phosphate dehydrogenase. Accumulation and binding ofTable 2 Monomer composition of mcl-PHA produced by meta
Strain C6∞ C8∞ C
KT2440 n.d. 11.8 ± 0.2 73
KT2440Δgcd n.d. 14.0 ± 0.4 71
KT2440-acoA n.d. 13.0 ± 0.6 69
KT2440Δgcd-acoA n.d. 14.8 ± 0.7 70
KT2440-pgl n.d. 12.2 ± 0.9 74
KT2440Δgcd-pgl n.d. 14.6 ± 0.3 73
n.d.: not detected, less than 0.2%.
∞: The data were determined by GC/MS and are given as relative molar fraction (%)
C12: 3-hydroxydodecanoate, C12:1: 3-hydroxy-5-cis-dodecanoate, and C14: 3-hydroxKDPG to HexR lead to derepression [35-37]. Furthermore,
the genes of PHA synthesis are subjected to a complex
control by catabolite regulation and various stress re-
sponses mediated by the complex RNA-dependent GacS
and Crc regulating systems, besides others [38-40]. In
order to understand the gene regulatory adaptation of the
newly engineered strains to enhanced PHA produc-
tion the gene expression compared to the parental
strains was analyzed using next generation sequencing
of transcripts (RNASeq). We are fully aware that major
adaptation processes might take place at the level of
enzyme regulation which cannot be made visible with
the employed approach. Samples were taken after
60 hours of cultivation, when the PHA concentration in
the cell reached its highest level. Strict cut-off parameters
(log change > 2 and a p-value < 0.05) were applied. First,
the gene expression of acoA overexpressing strains
was compared to the wild type KT2440 strain and the
KT2440Δgcd mutant strain (Table 2). Overall, 53 open
reading frames (ORFs) were found differentially tran-
scribed (12 up-regulated and 41 down-regulated) between
the KT2440 wild type strain with or without overex-
pressed acoA. Moreover, 108 ORFs (59 up-regulated andbolically engineered P. putida strains in flask experiments
10∞ C12∞ C12:1∞ C14∞
.0 ± 0.1 4.7 ± 0.2 9.4 ± 0.7 0.8 ± 0.3
.1 ± 0.8 4.6 ± 0.9 8.5 ± 0.4 1.1 ± 0.2
.1 ± 1.2 3.4 ± 0.7 10.5 ± 0.2 3.9 ± 0.2
.2 ± 1.4 5.1 ± 0.3 8.8 ± 0.1 0.7 ± 0.3
.1 ± 1.5 3.8 ± 0.5 9.9 ± 0.8 n.d.
.1 ± 0.8 3.7 ± 0.2 8.1 ± 0.5 0.5 ± 0.1
of C6: 3-hydroxyexanoate, C8: 3-hydroxyoctanoate, C10:3-hydroxydecanoate,
ytetradecanoate.
Figure 4 Growth and mcl-PHA production of the metabolically engineered strains KT2440-acoA (A) and KT2440Δgcd-acoA (B) in batch
cultures. Cells were grown in lab scale bioreactor in the presence of glucose 18.5 (g/L). Data are presented as mean values obtained from two
independent experiments.
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tome between the KT2440Δgcd strain with or without
overexpressed acoA. As expected, the strongest up-
regulated gene in both variant strains overexpressing
acoA was PP_0555 (acoA). Interestingly, also PP_0554(acoB) was found upregulated, however to a lesser extent
(Table 4). Most of the genes encoding for enzymes
related to the central and PHA synthesis metabolic
pathways showed only slight variations in their expression
levels (Table 4). Interestingly, the increased flux toward
Table 3 Physiological parameters of the wild type P. putida KT2440 and metabolically engineered strains in batch
culture grown with of glucose
Strain μmax (h
−1) YX/S
§ (g/g) Y2-ketoglut/S (g/g) Ygluconate/S (g/g) Y PHA/S (g/g)
KT2440 0.56 0.22 <0.001 0.64 0.05
KT2440Δgcd 0.42 0.23 <0.001 <0.001 0.08
KT2440-acoA 0.40 0.21 0.04 0.38 0.07
KT2440Δgcd-acoA 0.25 0.25 <0.001 <0.001 0.11
KT2440-pgl 0.33 0.21 0.07 0.55 0.05
KT2440Δgcd-pgl 0.21 0.24 <0.001 <0.001 0.08
§ Yx/s is calculated based on the total biomass concentration (true biomass + PHA content). Standard deviations of less than 10% were obtained in 3
independent experiments.
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expression of the isocitrate lyase gene, which encodes
the first enzyme of the glyoxylate shunt. One metabolic
consequence is a reduced NADH production in the TCA
cycle. A second consequence might be the channeling of
acetyl-CoA into the glyoxylate cycle. In agreement, it was
previously shown that inactivation of the isocitrate lyase
gene leads to increased PHA production [17]. Overall,
the gene expression data do not provide conclusive
explanations for the observed increase in PHA produc-
tion. Most likely regulatory effects at the enzyme level
might be responsible.
Next, the pgl overexpressing strains without increased
PHA production were analyzed for potential compensatory
gene regulatory activities. Of the 86 ORFs differentially
expressed in KT2440-pgl mutant strain compared to the
wild type strain, 77 corresponded to genes that were tran-
scriptionally up-regulated, whereas 9 genes were found with
decreased expression levels (Table 5). For KT2440Δgcd-pgl
mutant strain compared to the KT2440Δgcd mutant, 15
genes were found down-regulated while 117 ORFs were
found induced. As expected, the pgl overexpressing strains
revealed an increase of pgl mRNA. Glucose 6-phosphate
dehydrogenase (encoded by PP_1022, zwf) was found to be
highly up-regulated (>12 fold) in both strains harboring the
overexpression system (Table 5). Obviously, the initial goal
to enhance the flux from glucose toward KDPG was
achieved. The increased amounts of the metabolite might
have enhanced zwf-1 expression via HexR derepression.
Furthermore, expression differences were detected for the
pyruvate metabolism, where the genes encoding pyruvate
dehydrogenase (PP_0554), pyruvate carboxylase (PP_5347)
and phosphoenoylpyruvate (PP_1505) showed differential
expression levels (Table 5). At least for the wild type
strain harboring the overexpressed pgl a problematic
rearrangement of pyruvate metabolization occurred
which might be responsible for the observed production
phenotype. While the pyruvate dehydrogenase gene acoA
was found reduced, the pyruvate carboxylase gene acoC-2
was found induced (Table 5). In addition, induction of the
phosphoenolpyruvate carboxylase gene ppc was detected.The KT2440Δgcd mutant carrying overexpressed pgl did
not reveal this response. For the pgl overexpression
the observed gene regulatory response provides reasonable
explanations for the observed PHA production phenotype.
The role of NADPH and NADH in P. putida PHA
production
The production of mcl-PHAs in P. putida KT2440
requires NADPH+H+. P. putida catabolizes glucose via the
Entner-Doudoroff pathway and hence the NADPH+H+
producing glucose-6-phosphate dehydrogenase (Zwf)
is highly active. However, the attempts to further increase
the metabolic flux through this step by overproducing the
rate-limiting, succeeding enzyme (Pgl) failed to increase
PHA production (Figure 1). However, the flux of carbon
towards PHA was most likely hampered at the pyruvate
metabolization step in the pgl overexpression strain.
Interestingly, the transcriptome analyses revealed an
increased zwf gene expression. In order to determine
the contribution of the NADPH+H+ level in P. putida to
PHA production, NADPH +H+ versus NADP+ levels were
determined for the various bioengineered strains (Table 6).
The ratios of NADPH to NADP+ were measured using
UV/Vis spectrometry and quantified according to their
colorimetric changes at λ = 450 nm. At the maximum
mcl-PHA accumulation in the cell (60 h culture), we found
the NADPH/NADP+ ratios of all the PHA-overproducing
strains were lower compared to the corresponding wild
type P. putida KT2440 (Table 6). Clearly, the employed
metabolic engineering strategy increased the polyester
production in both strains (Table 3, Figure 3). As a
consequence of this increased flux of carbon into PHA
synthesis, more NADPH is needed to turn 3-ketoacyl-ACP
into (R)-3-hydroxyacyl-ACP (Figure 1). Therefore, the
levels of NADPH/NADP+ were lower for the engineered P.
putida strains (Table 6), in which pyruvate dehydrogenase
was overproduced. A totally different picture was observed
for the strains in which the pgl gene was overexpressed.
Here, an increase of the NADPH/NADP+ levels was de-
tected (Table 6). As already deduced from the transcrip-
tome data, the initial flux through the Entner-Doudoroff
Table 4 Expression profile of the genes belonging to PHA biosynthesis and central metabolic pathways in the
metabolically engineered P. putida strains compared to their parental strains
Gene name Locus tag Description Fold change§
Δgcd-acoA KT2440-acoA
PHA synthesis
phaI PP5008 PHA granule-associated 0.7 0.9
phaF PP5007 PHA granule-associated −0.3 0.2
phaC1 PP5003 PHA polymerase −0.2 0.7
phaC2 PP5005 PHA polymerase −0.6 −0.2
phaZ PP5004 PHA depolymerase 0.3 0.5
phaD PP5006 Transcriptional regulator −0.4 0.3
phaG PP1408 Acyl-transferase 1.5 −0.1
Transporters
oprB-1 PP1019 Porin −0.7 −1.0
oprB-2 PP1445 Porin −0.5 −0.6
Glycolysis/gluconeogenesis
glk PP1011 Glucokinase 0.2 −0.2
pgi PP1808 Glucose-6-phosphate isomerase −0.5 0.0
fbp PP5040 Fructose-1,6-bisphosphatase 0.6 0.4
fda PP4960 Fructose-1,6-bisphosphate aldolase 0.9 0.1
tpiA PP4715 Triosephosphate isomerase 0.8 0.6
gap1 PP1009 GAP dehydrogenase, type I −1.2 −0.4
gap2 PP2149 GAP dehydrogenase, type II 0.2 0.3
pgk PP4963 Phosphoglycerate kinase 0.2 0.1
pgm PP5056 Phosphoglyceromutase 0.4 0.1
eno PP1612 Phosphopyruvate hydratase 0.3 0.0
pyk PP1362 Pyruvate kinase −0.3 0.4
Pentose phosphate pathways
zwf1 PP1022 G6P dehydrogenase 0.9 0.2
zwf2 PP4042 0.1 −0.3
zwf3 PP5351 0.2 0.4
pgl PP1023 6-phosphogluconate dehydrogenase 0.5 −0.9
gnd PP4043 6-phosphoglucolacto dehydrogenase −0.6 −0.1
gnuK PP3416 Carbohydrate kinase −1.1 −0.6
kguK PP3378 Dehydroglucokinase 0.45 −0.4
kguD PP3376 2-Ketogluconate 6-phosphate reductase −0.7 −0.5
rpiA PP5150 Ribose-5-phosphate isomerase A 0.3 0.0
rpe PP0415 Ribulose-phosphate 3-epimerase −0.5 −0.1
tktA PP4965 Transketolase 0.3 0.7
tal PP2168 Transaldolase B 0.4 0.3
Entner-Doudoroff pathway
edd PP1010 6-Phosphogluconate dehydratase −0.3 −0.3
eda PP1024 KDPG aldolase 0.0 −0.5
Pyruvate metabolism
acoA PP0555 Pyruvate dehydrogenase 12.4 5.3
acoB PP0554 Pyruvate dehydrogenase 1.5 1.0
Borrero-de Acuña et al. Microbial Cell Factories 2014, 13:88 Page 9 of 15
http://www.microbialcellfactories.com/content/13/1/88
Table 4 Expression profile of the genes belonging to PHA biosynthesis and central metabolic pathways in the
metabolically engineered P. putida strains compared to their parental strains (Continued)
acoC PP0553 Pyruvate dehydrogenase 0.7 0.7
PP0545 Aldehyde dehydrogenase 0.1 −1.0
acsA PP4487 Acetyl-CoA synthetase 0.8 1.4
accC-2 PP5347 Pyruvate carboxylase 0.5 0.2
ppsA PP2082 Phosphoenolpyruvate synthase 0.5 0.4
ppc PP1505 Phosphoenolpyruvate carboxylase 0.5 0.4
TCA cycle
gltA PP4194 Citrate synthase 0.7 0.7
acnA PP2112 Aconitate hydratase 0.4 −0.4
acnB PP2339 Aconitate hydratase 0.7 0.3
icd PP4011 Isocitrate dehydrogenase 0.3 −0.5
sucA PP4189 2-Oxoglutarate dehydrogenase −0.7 −0.2
sucD PP4185 Succinyl-CoA synthetase sub alpha −0.1 −0.3
sucC PP4186 Succinyl-CoA synthetase sub beta 0.2 0.3
sdhA PP4191 Succinate dehydrogenase 0.3 0.4
fumC PP0944 Fumarate hydratase 0.5 −1.1
mdh PP0654 Malate dehydrogenase −0.4 −1.3
Glyoxylate shunt
aceA PP4116 Isocitrate lyase 2.9 1.3
glcB PP0356 Malate synthase 0.8 0.8
§Bold numbers represent a differentiated gene expression pattern.
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KDPG accumulation and an increased zwf-1 expression.
Consequently, sufficient NADPH was produced. However,
the increased flux of carbon towards PHA was lost at least
in one case at the pgl overexpression strains. Overall, gene
and most likely enzyme activity regulatory phenomena
prohibited further flux towards PHA production and
resulted in increased NADPH +H+ levels.
By overproducing the AcoA subunit of the pyruvate
dehydrogenase complex, there was a significant change on
NADH/NAD+ values in comparison to those found in their
parental strains (Table 6). P. putida strains with high PHA
production revealed high NADH/NAD+ ratio values. It was
shown before that intracellular NADH concentrations are
crucial for cell growth [41,42]. Similar observations of the
importance of the NADH/NAD+ ratio for PHA synthesis
from fatty acids in P. putida were published before [43-45].
Conclusion
We successfully continued our in silico metabolic
modeling based approach for the improvement of PHA
formation in P. putida. The predicted overexpression of
the pyruvate dehydrogenase subunit gene acoA in com-
bination with the deletion of the glucose dehydrogenase
gene gcd resulted in an increase of PHA production by
120%. Potential explanation for the observed PHAproduction phenotypes were derived from gene expression
and cofactor quantification analyses. Beyond this work on
microbial biopolymer production, in silico based meta-
bolic engineering has proven truly valuable for succinate
[46], 1,4 butandiol [47], bio-ethanol [48], and amino acids
[49,50], suggesting this strategy as highly promising to
breed superior producers industrial biotechnology.
Methods
Bacterial strains
Pseudomonas putida KT2440 (DSMZ, Braunschweig,
Germany) as wild type strain and the gene knock-out
mutants P. putida Δgcd [21] were used in this study
(Table 1). E. coli strain DH10b (Invitrogen, Darmstadt,
Germany) was employed for the amplification of
pJET1.2 derivatives (Promega, Darmstadt, Germany).
E. coli XL10-Gold (Stratagene, Waldbronn, Germany) was
used for replication of the pSEVA plasmids (pSEVA424,
pSEVA-pgl and pSEVA-acoA). The pSEVA plasmids
constitute a series of low-copy plasmids for the isopropyl
1-thio-β-D-galactopyranoside (IPTG) inducible overexpres-
sion of target genes [51]. Transformation of the P. putida
strains was accomplished via electroporation applying a
voltage of 2.5 V, 200 Ω and 25 μF, while E.coli
DH10b was transformed as previously described [52].
P. putida KT2440 and its Δgcd mutant were transformed
Table 5 Expression profile of the genes belonging to PHA biosynthesis and central metabolic pathways in the
metabolically engineered strains compared to their parental strains
Gene name Locus tag Description Fold change§
Δgcd-pgl KT2440-pgl
PHA synthesis
phaI PP5008 PHA granule-associated 0.6 −0.3
phaF PP5007 PHA granule-associated 0.3 −0.4
phaC1 PP5003 PHA polymerase −0.8 −0.1
phaC2 PP5005 PHA polymerase −0.7 −0.4
phaZ PP5004 PHA depolymerase −0.4 0.0
phaD PP5006 Transcriptional regulator 0.2 0.1
phaG PP1408 Acyl-transferase 2.1 0.2
Transporters
oprB-1 PP1019 Porin 0.4 −0.1
oprB-2 PP1445 Porin −0.4 −0.4
Glycolysis/gluconeogenesis
glk PP1011 Glucokinase 0.3 0.2
pgi PP1808 Glucose-6-phosphate isomerase −0.4 0.0
fbp PP5040 Fructose-1,6-bisphosphatase 0.3 −0.1
fda PP4960 Fructose-1,6-bisphosphate aldolase 0.6 −0.1
tpiA PP4715 Triosephosphate isomerase 0.4 0.5
gap1 PP1009 GAP dehydrogenase, type I −0.4 −0.2
gap2 PP2149 GAP dehydrogenase, type II −0.3 −0.2
pgk PP4963 Phosphoglycerate kinase 0.1 0.0
pgm PP5056 Phosphoglyceromutase 0.5 −0.3
eno PP1612 Phosphopyruvate hydratase 0.5 0.1
pyk PP1362 Pyruvate kinase −0.5 0.6
Pentose phosphate pathways
zwf1 PP1022 G6P dehydrogenase 5.2 3.6
zwf2 PP4042 0.2 −0.6
zwf3 PP5351 −0.1 −0.3
pgl PP1023 6-phosphogluconate dehydrogenase 9.3 7.8
gnd PP4043 6-phosphoglucolacto dehydrogenase 0.2 −0.3
gnuK PP3416 Carbohydrate kinase −0.1 0.3
kguK PP3378 Dehydroglucokinase 0.6 0.5
kguD PP3376 2-Ketogluconate 6-phosphate reductase 0.1 −0.1
rpiA PP5150 Ribose-5-phosphate isomerase A 0.3 −0.4
rpe PP0415 Ribulose-phosphate 3-epimerase 0.2 −0.1
tktA PP4965 Transketolase 0.7 0.3
tal PP2168 Transaldolase B 0.2 0.1
Entner-Doudoroff pathway
edd PP1010 6-Phosphogluconate dehydratase 0.2 0.1
eda PP1024 KDPG aldolase 0.4 −0.2
Pyruvate metabolism
acoA PP0555 Pyruvate dehydrogenase 1.3 −2.7
acoB PP0554 Pyruvate dehydrogenase 0.7 −0.8
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Table 5 Expression profile of the genes belonging to PHA biosynthesis and central metabolic pathways in the
metabolically engineered strains compared to their parental strains (Continued)
acoC PP0553 Pyruvate dehydrogenase 0.5 −1.2
PP0545 Aldehyde dehydrogenase 0.5 −0.9
acsA PP4487 Acetyl-CoA synthetase −0.3 −0.6
accC-2 PP5347 Pyruvate carboxylase 0.8 2.3
ppsA PP2082 Phosphoenolpyruvate synthase 0.2 −0.1
ppc PP1505 Phosphoenolpyruvate carboxylase 0.0 1.4
TCA cycle
gltA PP4194 Citrate synthase −0.2 0.7
acnA PP2112 Aconitate hydratase 0.8 −0.5
acnB PP2339 Aconitate hydratase −0.2 0.3
icd PP4011 Isocitrate dehydrogenase −0.3 −0.3
sucA PP4189 2-Oxoglutarate dehydrogenase −0.6 0.2
sucD PP4185 Succinyl-CoA synthetase sub alpha −0.2 0.5
sucC PP4186 Succinyl-CoA synthetase sub beta −0.1 0.1
sdhA PP4191 Succinate dehydrogenase −0.7 0.3
fumC PP0944 Fumarate hydratase 1.1 −0.4
mdh PP0654 Malate dehydrogenase 0.8 −0.8
Glyoxylate shunt
aceA PP4116 Isocitrate lyase 1.2 −1.1
glcB PP0356 Malate synthase −0.4 −0.1
p-value < 0.05.
§Bold numbers represent a differentiated gene expression pattern.
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the pyruvate dehydrogenase subunit A (AcoA) and
6-phosphogluconolactonase (Pgl), respectively.
Genetic techniques and construction of bacterial strains
The 978 bp acoA and 729 bp pgl genes were PCR amplified
using primer pairs acoAFw/acoARv and pglFw/pglRv,
respectively. Used primers sequences are listed in Table 1.
The forward primers (acoA/Fw, pgl/Fw) of both genes
encoded an EcoRI restriction site, a consensus Ribosomal
Binding Site (RBS) sequence (AGGAGG), eight con-
served nucleotides downstream (AAAAACAT) and 18
nucleotides from the gene of interest [51]. Both reverseTable 6 Levels of the NAD+, NADH, NADP+, and NADPH cofac
PHA producing conditions
Strain Cofactor level (mmol/g rC
NAD+ NADH NADP+
KT2440 7.62 ± 0.86 0.67 ± 0.08 3.22 ±
KT2440Δgcd 6.01 ± 0.67 1.75 ± 0.36 4.49 ±
KT2440-acoA 6.25 ± 0.42 2.02 ± 0.15 6.48 ±
KT2440Δgcd-acoA 6.88 ± 0.33 2.94 ± 0.15 3.98 ±
KT2440-pgl 5.59 ± 0.14 1.82 ± 0.10 2.58 ±
KT2440Δgcd-pgl 10.81 ± 0.50 2.18 ± 0.38 2.30 ±
*rCDW: residual cell dry weight.primers (acoA/Rv, pgl/Rv) encoded an XbaI restriction site
and the last 18 nucleotides of target gene sequences
(Table 1). Amplified genes were cloned into pJET1.2
resulting in pJET1.2-acoA and pJET1.2-pgl, respectively.
The cloned genes were excised from their host vectors via
EcoRI and XbaI restriction and subsequently cloned into
the EcoRI-XbaI sites of pSEVA424 resulting in pSEVA-pgl
and pSEVA-acoA, respectively.
Shake flask cultivation
P. putida strains were kept as frozen stock in 25%
glycerol at −80°C. Prior to inoculation they were streaked
on Luria Bertani agar plates and incubated for one day attors and their ratios of various P. putida strains under
DW)* Cofactor ratio
NADPH NADH/NAD+ NADPH/NADP+
0.38 2.67 ± 0.07 0.09 0.83
0.12 1.31 ± 0.32 0.30 0.29
0.48 0.87 ± 0.27 0.32 0.13
0.46 0.96 ± 0.36 0.43 0.24
0.40 3.07 ± 0.41 0.33 1.19
0.15 3.71 ± 1.23 0.20 1.62
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inoculated in 50 mL shake flasks containing 10 ml LB and
incubated overnight under aerobic conditions at 30°C and
shaking at 180 rpm. To start the PHA-producing process
1 L baffled shake flasks containing 200 mL of defined
culture medium were inoculated to an initial OD595 of
0.05 and placed in a rotary shaker (180 rpm) under
aerobic conditions at 30°C. Each culture was carried out
by triplicate. P. putida strains were grown in a defined
M9 mineral medium consisting of per liter 12.8 g
Na2HPO4
. 7H2O, 3 g KH2O4, 1 g NH4Cl, and 0.5 g
NaCl. This basic solution was autoclaved and subsequently
supplemented with 0.12 g of MgSO4
. H2O and a trace
element solution made of: 6.0 mg/L FeSO4
. 7H2O, 2.7 mg/L
CaCO3, 2.0 mg/L ZnSO4
. H2O, 1.16 mg/L MnSO4
. H2O,
0.37 mg/L CoSO4
. 7H2O, 0.33 mg/L CuSO4
. 5H2O, 0.08 mg/L
H3BO3, and 20 g/L glucose (all filter-sterilized). Antibiotics
were 62.5 μg/mL streptomycin (Sm) for E. coli XL10-Gold,
100 μg/mL streptomycin for P. putida strains and
100 μg/mL ampicillin (Ap) for E. coli DH10b.
Bioreactor fermentations
P. putida strains were grown in M9 medium supplemented
with 18.5 g/L glucose, and antibiotic as required. Bioreactor
batch fermentations were carried out in a 2 L top-bench
BIOSTAT B1 bioreactor (Sartorius B Systems GmbH,
Melsungen, Germany) with a working volume of 1.5 L, at
30°C. The aeration rate was set to 500 mL L−1 min−1 using
a mass flow controller (PR4000, MKS Instruments,
Wilmington, MA, USA). The dissolved oxygen level
was kept above 20% air saturation by control of the
agitation speed up to a maximum of 900 rpm. The
pH was maintained at 7.0 by automatic pH controlled
addition of 500 mM H2SO4 or 1 M of KOH.
Cell growth was monitored via OD measurements at
600 nm (Ultraspec 2000, Hitachi, Japan). The cell dry
weight was determined gravimetrically after harvesting
bacteria from 10 mL culture broth for 10 min at 4°C and
10,000 rpm (Eppendorf 5810 R, Hamburg, Germany),
washing with distilled water, and drying of the obtained
pellet at 100°C. The ammonium concentration in cell-free
extracts was measured by a photometric test (LCK 303
kit, Hach Lange, Danaher, USA). The glucose concentra-
tion in the cultivation supernatant was analyzed after
appropriate dilution by HPLC chromatography (HPLC
Agilent 1260, Agilent, Krefeld, Germany) through an
8 mm Rezex ROA-organic acid H column (Phenomenex,
USA) at a flow rate of 0.5 mL · min−1 at 65°C using
0.013 N H2SO4 as the mobile phase, followed by detection
using a RID detector (Agilent series1260). Gluconate and
2-keto-gluconate were quantified by HPLC chromatog-
raphy using an Aminex HPX 87 H column (Biorad,
Hercules, CA, USA) on a Hitachi HPLC system (Hitachi
Elite LaChrom, Krefeld, Germany) and 12.5 mM H2SO4 asthe mobile phase at a flow rate of 0.5 mL min−1 at 45°C.
Compounds were quantified by UV detection at 220 nm.
PHA characterization and quantification
Composition analyses of the polymer produced and cellular
PHA content concentration determination were performed
by gas chromatography (GC) and mass spectrometry (MS)
of the methanolyzed polyester. For PHA production corre-
sponding P. putida strains were streaked on LB agar plates
and incubated for one day at 30°C. Single colonies were
then picked from the plate, inoculated in a 50 mL shake
flask containing 10 mL of the above described medium and
incubated overnight under aerobic conditions at 30°C and
180 rpm (Innova, Enfield, USA). To begin the PHA-
accumulating process, 1 L baffled shake flasks containing
200 mL of culture medium were inoculated at an initial
OD595nm of 0.05 and incubated under aerobic conditions at
30°C. Subsequently, 10 mL of the culture were centrifuged
for 10 min at 4°C and 9,000 x g, followed by a washing step
with distilled water and lyophilization. Methanolysis was
carried out by suspending 5 – 10 mg of lyophilized cell pel-
let in 2 mL of chloroform and 2 mL of methanol containing
15% sulfuric acid and 0.5 mg ·mL−1 3-methylbenzoic acid
as internal standard. Incubation followed at 100°C for 4 h.
After cooling, 1 mL of demineralized water was added. The
organic phase containing the resulting methyl esters of the
monomers of the polymers of interest were analyzed by
GC-MS on a Varian GC-MS system 450GC/240MS ion
trap mass spectrometer operated by the software MS
Workstation 6.9.3 (Varian Inc., Agilent Technologies,
Böblingen, Germany). For this purpose, 1 mL of the organic
phase was injected into the gas chromatograph at a split ra-
tio of 1:10. Separation of the analytes of interest (i.e. the
methyl esters of 3-hydroxyexanoate, 3-hydroxyoctanoate,
3-hydroxydecanoate, 3-hydroxydodecanoate, 3-hydroxy-5-
cis-dodecanoate, 3-hydroxytetradecanoate) was achieved
by chromatography through a FactorFour VF-5 ms capil-
lary column (30 m X 0.25 mm i.d. X 0.25 mm film thick-
ness). Helium was used as carrier gas at a flow rate of
0.9 mL · min−1. The injector and transfer line temperature
were 275°C and 300°C, respectively. The temperature pro-
gram was: initial temperature 40°C for 2 min, then from
40°C up to 150°C at a rate of 5°C min−1 and finally up
to 280°C at a rate of 10°C min−1. Positive ions were
obtained using electron ionization at 70 eV. The mass spec-
tra were generated by scanning ions of m/z 50 to m/z 650.
The PHA content (%wt) was defined as the percentage of
polyhydroxyalkanoate in the cell dry weight (CDW).
NADH and NADPH quantification
The intracellular NAD+, NADH, NADP+ and NADPH con-
centrations were measured employing an NADP/NADPH
Colorimetric Quantitation Kit (Biovision, Abcam, UK).
Crude cell lysates were obtained by undertaking various
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photometrically quantified by measuring colorimetric
changes at 450 nm.
Transcriptome analysis via RNAseq
Isolation of total RNA from corresponding 10 mL P.
putida culture was performed using the RNeasy kit
(Qiagen, Venlo, Netherland), according to the instructions
provided by the manufacturer. Library preparation was
done as described in [51]. Briefly, ribosomal RNA removal
was performed with the MICROExpress Bacterial RNA
enrichment kit using the Pseudomonas module (Ambion,
Life Technologies, Darmstadt, Germany) according to the
manufacturer’s instructions. The RNA was fragmented to
a median fragment size of 200 nt by sonication using
Covaris Adaptive Focused Acoustics device (Covaris, LGC
Genomics, Herts, UKStrand-specific cDNA libraries
were generated by previous RNA-Adapter ligation and
subsequent reverse transcription. Hereby the ligated
5′-RNA-Adapter contained one of 24 different 6 nt
barcode sequences [51], which allowed multiplexing of
several libraries in a single Illumina lane for sequencing.
Up to 20 libraries were pooled and treated with
duplex-specific nuclease (DSN) for additional rRNA
removal. Sequencing was performed on an Illumina
HiSeq generating single-end reads with a length of 50
base pairs. Computational analysis of the raw sequence
data obtained in Illumina FASTQ-format was performed
as described previously by [53], with some modifications
Mapping was performed using stampy, a short-read aligner
that allows for gapped alignments [54] for quantification of
gene expression. The reads per gene (rpg) values of all
genes were calculated from the SAM output files. Testing
for differential expression against KT2440 (four biological
replicates) was performed with DESeq [55], an R software
package that uses a statistical model based on the negative
binomial distribution.
Protein quantification
After 60 hours, 10 mL cultures were withdrawn and cells
were harvested by centrifugation. Proteins from up to
50 μg cell pellet were separated via SDS-PAGE [56].
Resulting SDS gels were stained using Coomassie Brillant
Blue and protein amounts quantified densiometrically on
a GS-800 scanner device.
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